📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report. (2016)

First Author: Liyanage SE

Attributed to: Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/atvbaha.115.306681

PubMed Identifier: 26603154

Publication URI: http://europepmc.org/abstract/MED/26603154

Type: Journal Article/Review

Volume: 36

Parent Publication: Arteriosclerosis, thrombosis, and vascular biology

Issue: 1

ISSN: 1079-5642